A
$ Value
$34K
Shares
145
Price
$232
Filed
Oct 2
Insider
Name
RAPP EDWARD J
Title
—
CIK
0001171780
Roles
Director
Transaction Details
Transaction Date
2025-09-30
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
28,152
Footnotes
Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. | Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
Filing Info
RAPP EDWARD J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-10 | XOS | A | $0 |
| 2026-03-31 | ABBV | A | $34K |
| 2026-01-10 | XOS | A | $0 |
| 2025-12-31 | ABBV | A | $34K |
| 2025-10-10 | XOS | A | $0 |
| 2025-09-30 | ABBV | A | $34K |
| 2025-07-10 | XOS | A | $0 |
| 2025-07-10 | XOS | A | $0 |
| 2025-06-30 | ABBV | A | $33K |
| 2025-05-09 | ABBV | A | $0 |
Other Insiders at ABBV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RAPP EDWARD J | — | — | 2026-03-31 |
| Alpern Robert J | — | — | 2026-03-31 |
|
SALEKI-GERHARDT AZITA
EVP, CHIEF OPERATIONS OFFICER
|
— | — | 2026-02-18 |
|
Michael Robert A.
CHIEF EXECUTIVE OFFICER
|
— | — | 2026-02-18 |
|
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
|
— | — | 2026-02-18 |
|
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
|
— | — | 2026-02-18 |
|
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
|
— | — | 2026-02-18 |
|
Siatis Perry C
EVP, GC AND SECRETARY
|
— | $5.1M | 2026-02-25 |
| Quaggin Susan E | — | — | 2026-03-31 |
|
Thakkar Roopal
EVP, R&D and CSO
|
— | — | 2026-02-18 |
|
Purdue David Ryan
SVP, Controller
|
— | — | 2026-02-18 |
|
Crum Demetris D
EVP, CHIEF HR OFFICER
|
— | — | 2026-02-18 |